Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
581.21
Dollar change
+1.84
Percentage change
0.32
%
IndexS&P 500 P/E37.62 EPS (ttm)15.45 Insider Own0.19% Shs Outstand386.65M Perf Week-0.50%
Market Cap221.62B Forward P/E24.01 EPS next Y24.20 Insider Trans-15.83% Shs Float380.59M Perf Month1.60%
Income6.00B PEG5.58 EPS next Q4.72 Inst Own92.02% Short Float0.90% Perf Quarter9.32%
Sales42.86B P/S5.17 EPS this Y-0.03% Inst Trans0.05% Short Ratio2.14 Perf Half Y16.64%
Book/sh120.87 P/B4.81 EPS next Y12.34% ROA6.12% Short Interest3.43M Perf Year4.87%
Cash/sh21.20 P/C27.42 EPS next 5Y6.74% ROE13.22% 52W Range415.60 - 603.82 Perf YTD9.50%
Dividend Est.1.52 (0.26%) P/FCF31.99 EPS past 5Y16.37% ROI7.56% 52W High-3.74% Beta0.80
Dividend TTM1.44 (0.25%) Quick Ratio1.39 Sales past 5Y12.53% Gross Margin39.06% 52W Low39.85% ATR (14)9.32
Dividend Ex-DateMar 14, 2024 Current Ratio1.75 EPS Y/Y TTM-12.51% Oper. Margin17.39% RSI (14)54.18 Volatility1.69% 1.59%
Employees122000 Debt/Eq0.78 Sales Y/Y TTM-4.58% Profit Margin13.99% Recom1.67 Target Price599.20
Option/ShortYes / Yes LT Debt/Eq0.70 EPS Q/Q4.76% Payout9.06% Rel Volume0.65 Prev Close579.37
Sales Surprise1.43% EPS Surprise0.46% Sales Q/Q-4.93% EarningsJan 31 BMO Avg Volume1.60M Price581.21
SMA20-0.57% SMA502.88% SMA20010.66% Trades Volume1,036,570 Change0.32%
Date Action Analyst Rating Change Price Target Change
Mar-18-24Resumed Citigroup Neutral $620
Jan-24-24Downgrade Barclays Overweight → Equal Weight $475 → $555
Jan-08-24Downgrade Bernstein Outperform → Mkt Perform
Dec-18-23Initiated HSBC Securities Buy $610
Dec-13-23Initiated Wolfe Research Outperform $575
Oct-26-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-25-23Upgrade Wells Fargo Underweight → Equal Weight $52 → $475
Sep-28-23Initiated Bernstein Outperform $603
Sep-06-23Resumed Citigroup Buy $625
Jul-19-23Reiterated Robert W. Baird Outperform $670 → $664
Today 02:36PM
02:07PM
08:01AM
Mar-27-24 06:00PM
Mar-26-24 06:15PM
08:02AM Loading…
08:02AM
Mar-22-24 09:41AM
Mar-21-24 10:25AM
02:53AM
Mar-20-24 06:00PM
06:29AM
Mar-19-24 08:00AM
Mar-18-24 06:15PM
Mar-17-24 05:47PM
Mar-14-24 12:00PM
09:38AM Loading…
09:38AM
09:00AM
Mar-12-24 06:00PM
09:09AM
Mar-11-24 03:04PM
10:20AM
Mar-06-24 06:00PM
02:45PM
Mar-05-24 06:00AM
Mar-01-24 11:30AM
09:00AM
08:00AM
Feb-29-24 09:30PM
06:00PM
03:04PM
08:00AM Loading…
Feb-28-24 08:00AM
Feb-26-24 01:19PM
Feb-23-24 12:02AM
Feb-21-24 05:00PM
Feb-20-24 06:00AM
Feb-19-24 10:55AM
Feb-17-24 01:29PM
Feb-15-24 04:13PM
06:11AM
Feb-14-24 10:01AM
Feb-13-24 02:41PM
Feb-10-24 10:25AM
Feb-06-24 08:43AM
08:12AM
06:01AM
Feb-02-24 11:02AM
06:19AM
Jan-31-24 10:31PM
04:43PM
03:04PM
12:15PM
12:14PM
12:07PM
11:23AM
10:38AM
09:30AM
09:13AM
07:17AM
07:10AM
06:37AM
06:27AM
06:17AM
06:11AM
06:05AM
06:00AM
Jan-30-24 07:08PM
09:15AM
06:01AM
02:30AM
Jan-29-24 12:56PM
Jan-26-24 09:15AM
Jan-24-24 03:08PM
Jan-22-24 06:00PM
Jan-18-24 06:15PM
Jan-17-24 07:57AM
Jan-16-24 11:57AM
06:00AM
Jan-12-24 06:00PM
Jan-11-24 06:15PM
Jan-10-24 12:01PM
11:58AM
Jan-05-24 06:00PM
05:19AM
05:19AM
02:37AM
Jan-04-24 06:15PM
04:01PM
08:00AM
12:32AM
Jan-03-24 04:12PM
12:01PM
10:09AM
08:00AM
Jan-02-24 08:00AM
Dec-30-23 09:30AM
09:27AM
Dec-27-23 06:15PM
Dec-26-23 10:51AM
07:08AM
Dec-22-23 08:56AM
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChairman & CEOMar 13 '24Option Exercise190.5910,0001,905,900133,816Mar 14 04:03 PM
CASPER MARC NChairman & CEOMar 13 '24Sale594.5810,0005,945,759123,816Mar 14 04:03 PM
Britt Lisa P.Sr. VP and Chief HR OfficerMar 12 '24Option Exercise198.8514,3452,852,54525,768Mar 13 04:31 PM
CASPER MARC NChairman & CEOMar 12 '24Option Exercise190.5910,0001,905,900133,816Mar 13 05:24 PM
Britt Lisa P.Sr. VP and Chief HR OfficerMar 12 '24Sale598.9014,3458,591,22017,323Mar 13 04:31 PM
CASPER MARC NChairman & CEOMar 12 '24Sale597.9810,0005,979,758123,816Mar 13 05:24 PM
CASPER MARC NChairman & CEOMar 11 '24Option Exercise190.5910,0001,905,900135,816Mar 13 05:24 PM
CASPER MARC NChairman & CEOMar 11 '24Sale595.3610,0005,953,598125,816Mar 13 05:24 PM
CASPER MARC NChairman & CEOFeb 29 '24Option Exercise190.5910,0001,905,900135,816Mar 04 04:36 PM
CASPER MARC NChairman & CEOFeb 29 '24Sale571.0810,0005,710,818125,816Mar 04 04:36 PM
CASPER MARC NChairman & CEOFeb 28 '24Option Exercise190.5910,0001,905,900138,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 28 '24Sale570.1810,0005,701,759128,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 27 '24Option Exercise190.5910,0001,905,900138,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 27 '24Sale564.7210,0005,647,196128,485Feb 29 04:56 PM
CASPER MARC NChairman & CEOFeb 15 '24Sale550.625,5473,054,29043,608Feb 20 04:51 PM
Spar Debora LDirectorFeb 12 '24Sale546.9716489,7031,207Feb 14 04:36 PM
Boxer Michael ASVP and General CounselFeb 07 '24Option Exercise192.9814,5662,810,94727,467Feb 08 04:53 PM
Boxer Michael ASVP and General CounselFeb 07 '24Sale562.0014,5668,186,09212,901Feb 08 04:53 PM
CASPER MARC NChairman & CEOFeb 07 '24Sale555.6310,0005,556,28749,155Feb 08 04:51 PM
CASPER MARC NChairman & CEONov 07 '23Option Exercise157.681,600252,288132,775Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 07 '23Sale460.251,600736,404131,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 06 '23Option Exercise157.6810,0001,576,800141,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 06 '23Sale454.4110,0004,544,053131,175Nov 08 04:09 PM
CASPER MARC NChairman & CEONov 03 '23Option Exercise157.6810,0001,576,800141,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 03 '23Sale456.1510,0004,561,459131,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 02 '23Option Exercise157.6810,0001,576,800141,175Nov 06 04:34 PM
CASPER MARC NChairman & CEONov 02 '23Sale445.4910,0004,454,880131,175Nov 06 04:34 PM
Pettiti GianlucaExecutive Vice PresidentAug 30 '23Option Exercise253.993,000761,97020,556Aug 31 04:15 PM
Pettiti GianlucaExecutive Vice PresidentAug 30 '23Sale557.773,0001,673,31017,556Aug 31 04:15 PM
CASPER MARC NChairman & CEOAug 08 '23Option Exercise157.681,600252,288136,930Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 08 '23Sale550.601,600880,960135,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 07 '23Option Exercise157.6810,0001,576,800145,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 07 '23Sale551.9410,0005,519,370135,330Aug 09 04:01 PM
CASPER MARC NChairman & CEOAug 04 '23Option Exercise157.6810,0001,576,800145,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 04 '23Sale550.3310,0005,503,317135,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 03 '23Option Exercise157.6810,0001,576,800151,330Aug 07 04:05 PM
CASPER MARC NChairman & CEOAug 03 '23Sale549.0010,0005,490,050141,330Aug 07 04:05 PM
Williamson StephenSr. VP and CFOAug 01 '23Option Exercise190.5914,1002,687,31941,493Aug 02 04:33 PM
Williamson StephenSr. VP and CFOAug 01 '23Sale550.0014,1007,755,00027,393Aug 02 04:33 PM
Williamson StephenSr. VP and CFOJul 31 '23Option Exercise190.5915,0002,858,85042,393Aug 02 04:33 PM
Williamson StephenSr. VP and CFOJul 31 '23Sale557.4215,0008,361,30027,393Aug 02 04:33 PM
Boxer Michael ASVP and General CounselJun 26 '23Buy526.1542,10513,101Oct 06 04:23 PM
CASPER MARC NChairman & CEOMay 09 '23Option Exercise157.681,600252,288142,930May 10 04:13 PM
CASPER MARC NChairman & CEOMay 09 '23Sale534.821,600855,710141,330May 10 04:13 PM
CASPER MARC NChairman & CEOMay 08 '23Option Exercise157.6810,0001,576,800151,330May 10 04:13 PM
CASPER MARC NChairman & CEOMay 08 '23Sale544.4010,0005,444,003141,330May 10 04:13 PM
CASPER MARC NChairman & CEOMay 05 '23Option Exercise157.6810,0001,576,800151,330May 08 04:21 PM
CASPER MARC NChairman & CEOMay 05 '23Sale545.2210,0005,452,236141,330May 08 04:21 PM
CASPER MARC NChairman & CEOMay 04 '23Option Exercise157.6810,0001,576,800151,330May 08 04:21 PM
CASPER MARC NChairman & CEOMay 04 '23Sale546.9810,0005,469,779141,330May 08 04:21 PM